Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial
Ann Surg Oncol
.
2017 Dec;24(Suppl 3):566-567.
doi: 10.1245/s10434-017-6174-y.
Epub 2017 Nov 28.
Authors
Daniel Rea
1
,
Adele Francis
2
,
Matthew Wallis
3
,
Jeremy Thomas
4
,
John Bartlett
5
,
Sarah Bowden
6
,
David Dodwell
7
,
Lesley Fallowfield
8
,
Claire Gaunt
6
,
Andrew Hanby
9
,
Valerie Jenkins
8
,
Lucy Matthews
8
,
Sarah Pinder
10
,
Sarah Pirrie
6
,
Malcolm Reed
11
,
Margaret Wilcox
12
,
Tracy Roberts
13
,
Cliona Kirwan
14
,
Cassandra Brookes
15
,
Patricia Fairbrother
12
,
Lucinda Billingham
6
,
Andrew Evans
16
,
Jennie Young
6
Affiliations
1
University of Birmingham, Cancer Research UK Clinical Trials Unit (CRCTU), Birmingham, UK.
[email protected]
.
2
University Hospitals Birmingham, Birmingham, UK.
3
Addenbrooke's Hospital, Cambridge, UK.
4
Western General Hospital, Edinburgh, UK.
5
Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada.
6
University of Birmingham, Cancer Research UK Clinical Trials Unit (CRCTU), Birmingham, UK.
7
St James's Hospital, Leeds, UK.
8
SHORE-C, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
9
University of Leeds, Leeds, UK.
10
King's College London, London, UK.
11
Brighton and Sussex Medical School, Brighton, UK.
12
Independent Cancer Patients' Voice, England, UK.
13
University of Birmingham, Birmingham, UK.
14
University Hospital of South Manchester, Wythenshawe, Manchester, UK.
15
University of Leicester, Leicester, UK.
16
University of Dundee, Dundee, UK.
PMID:
29185098
DOI:
10.1245/s10434-017-6174-y
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms*
Carcinoma, Intraductal, Noninfiltrating*
Humans
Random Allocation
Risk
Grants and funding
11/36/16/DH_/Department of Health/United Kingdom
15958/CRUK_/Cancer Research UK/United Kingdom
NIHR-CS-011-014/DH_/Department of Health/United Kingdom